These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36650694)

  • 1. Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective.
    Abdelhafiz AH
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):53-65. PubMed ID: 36650694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotype.
    Sinclair AJ; Pennells D; Abdelhafiz AH
    Aging Clin Exp Res; 2022 Sep; 34(9):1949-1967. PubMed ID: 35723859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triad of impairment in older people with diabetes-reciprocal relations and clinical implications.
    Abdelhafiz AH; Davies PC; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Mar; 161():108065. PubMed ID: 32044347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glycemic control on frailty: a multidimensional perspective.
    Abdelhafiz AH
    Hosp Pract (1995); 2023 Aug; 51(3):124-134. PubMed ID: 37056204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty and safety: the example of diabetes.
    Abbatecola AM; Olivieri F; Corsonello A; Strollo F; Fumagalli A; Lattanzio F
    Drug Saf; 2012 Jan; 35 Suppl 1():63-71. PubMed ID: 23446787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
    Abbatecola AM; Maggi S; Paolisso G
    Drugs Aging; 2008; 25(11):913-25. PubMed ID: 18947259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people.
    Emmerton D; Abdelhafiz A
    Hosp Pract (1995); 2021 Aug; 49(3):164-175. PubMed ID: 33729898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic oral treatment in older people: does frailty matter?
    Abbatecola AM; Paolisso G; Corsonello A; Bustacchini S; Lattanzio F
    Drugs Aging; 2009 Dec; 26 Suppl 1():53-62. PubMed ID: 20136169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of frailty in older people with diabetes as a function of glycaemic control and hypoglycaemic therapy: a review.
    Keegan GL; Bhardwaj N; Abdelhafiz AH
    Expert Rev Endocrinol Metab; 2023; 18(5):361-375. PubMed ID: 37489773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention.
    Espinoza SE; Jiwani R; Wang J; Wang CP
    Clin Ther; 2019 Mar; 41(3):376-386. PubMed ID: 30851950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin in Type 2 Diabetes: Evidence for its Beneficial Effects on Frailty and Sarcopenia.
    Pyrgioti EE; Karakousis ND; Georgakopoulos PN; Papanas N
    Curr Diabetes Rev; 2024; 20(3):e270723219177. PubMed ID: 37497698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Joya-Galeana J; Fernandez M; Cervera A; Reyna S; Ghosh S; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Diabetes Metab Res Rev; 2011 May; 27(4):373-82. PubMed ID: 21309063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin.
    Bahat G; Catikkas NM; Karan MA; Petrovic M
    Acta Clin Belg; 2022 Aug; 77(4):727-734. PubMed ID: 34251983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes.
    Sumantri S; Setiati S; Purnamasari D; Dewiasty E
    Acta Med Indones; 2014 Jul; 46(3):183-8. PubMed ID: 25348180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2020 Sep; 34(9):107639. PubMed ID: 32595017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attention to the use of oral anti-diabetic medication in older adults with type 2 diabetes].
    Jojima T; Aso Y
    Nihon Rinsho; 2013 Nov; 71(11):1987-92. PubMed ID: 24397171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes.
    Liu P; Pan Y; Song Y; Zhou Y; Zhang W; Li X; Li J; Li Y; Ma L
    Eur J Med Res; 2023 Feb; 28(1):65. PubMed ID: 36732827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.
    Abdelhafiz AH; Sinclair AJ
    Curr Diab Rep; 2019 Feb; 19(4):15. PubMed ID: 30806826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2022 Apr; 36(4):108144. PubMed ID: 35151546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?
    Paolisso G; Monami M; Marfella R; Rizzo MR; Mannucci E
    Adv Ther; 2012 Mar; 29(3):218-33. PubMed ID: 22411425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.